Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Public ClinicalTrials.gov record NCT01767155. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Open-label, randomized, active-controlled, two-arm Phase III study to compare the efficacy and safety of AEZS-108 and doxorubicin.
Study identification
- NCT ID
- NCT01767155
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 511 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2013 (Actual)
- Primary completion
- Jan 30, 2017 (Actual)
- Completion
- Jan 30, 2017 (Actual)
- Last update posted
- Jul 31, 2018
2013 – 2017
United States locations
- U.S. sites
- 28
- U.S. states
- 22
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph's Hospital and Medical Center | Phoenix | Arizona | 85013 | — |
| USC Norris Hospital and LAC+USC Medical Center | Los Angeles | California | 90033 | — |
| University of California, Irvine - Medical Center | Orange | California | 92868-3200 | — |
| University of Colorado | Aurora | Colorado | 80045 | — |
| Hartford Hospital | Hartford | Connecticut | 06106 | — |
| The Hospital of Central Connecticut | New Britain | Connecticut | 06050 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Northside Hospital | Atlanta | Georgia | 30342 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| Women's Cancer Center | Covington | Louisiana | 70433 | — |
| University of Maryland Greenebaum Cancer Center | Baltimore | Maryland | 21201 | — |
| Massachusetts General Hospital Cancer Center | Boston | Massachusetts | 02114 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| Washington University School of Medecine | St Louis | Missouri | 63110 | — |
| Memorial Sloan-Kettering Cancer Institute | New York | New York | 10065 | — |
| Hope Women's Cancer Centers / Mission Hospital, Inc. | Asheville | North Carolina | 28806 | — |
| Levine Cancer Institute | Charlotte | North Carolina | 28204 | — |
| Roger Maris Cancer Center | Fargo | North Dakota | 58122 | — |
| Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | — |
| Peggy and Charles Oklahoma Cancer Center | Oklahoma City | Oklahoma | 73104 | — |
| Hollings Cancer Center, MUSC | Charleston | South Carolina | 29425 | — |
| Sanford Research/USD | Sioux Falls | South Dakota | 57104 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390-9179 | — |
| University of Virginia | Charlottesville | Virginia | 22908 | — |
| Inova Fairfax Hospitals | Falls Church | Virginia | 22024 | — |
| Henrico Doctor's Hospital | Richmond | Virginia | 23229 | — |
| Froedtert & The Medical College of Wisconsin, Inc. | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 95 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01767155, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2018 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01767155 live on ClinicalTrials.gov.